S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer

Keywords

Breast cancerOncologyMedicineCancerEstrogen receptorEstrogenInternal medicineMammary glandFraction (chemistry)Chemistry

Affiliated Institutions

University of Pittsburgh US

Related Publications

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Soonmyung Paik , Steven Shak , Gong Tang +12 more

The recurrence score has been validated as quantifying the likelihood of distant recurrence in tamoxifen-treated patients with node-negative, estrogen-receptor-positive breast c...

2004 New England Journal of Medicine 6215 citations

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Harold J. Burstein , Lyndsay N. Harris , P. Kelly Marcom +15 more

Purpose: Trastuzumab-based therapy improves survival for women with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. We conducted a multicenter p...

2003 Journal of Clinical Oncology 343 citations

Incidence and implications of HER2 and hormonal receptor overexpression in newly diagnosed metastatic breast cancer (MBC)

F Penault–Llorca , Anne Vincent‐Salomon , M-C Mathieu +3 more

764 Background: Overexpression of the HER2 receptor protein predicts a worse prognosis and higher metastatic risk in patients (pts) with breast cancer. HER2 positivity also has ...

2005 Journal of Clinical Oncology 18 citations

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano , Robert J. Gray , Della Makower +27 more

Adjuvant endocrine therapy and chemoendocrine therapy had similar efficacy in women with hormone-receptor-positive, HER2-negative, axillary node-negative breast cancer who had a...

2018 New England Journal of Medicine 2202 citations

Breast Cancer Treatment

Adrienne G. Waks , Eric P. Winer

Breast cancer consists of 3 major tumor subtypes categorized according to estrogen or progesterone receptor expression and ERBB2 gene amplification. The 3 subtypes have distinct...

2019 JAMA 4488 citations

Publication Info

Year: 1998
Type: article
Volume: 51
Issue: 3
Pages: 239-253
Citations: 68
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    John Bryant, 
                                
                                    Bernard Fisher, 
                                
                                    Nurten Gündüz
                                
                                et al.
                            
                            (1998). 
                            S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer. 
                            Breast Cancer Research and Treatment
                            , 51
                            (3)
                            , 239-253.
                            https://doi.org/10.1023/a:1006184428857
                        

Identifiers

DOI: 10.1023/a:1006184428857